These drugs help the kidneys by removing salt and water, which lowers blood pressure
Un grupo nuevo de #frmacos ha revolucionado el tratamiento para la #diabetes y la #obesidad
The result is a synergistic, sustained increase in GH and downstream IGF-1 more physiologically complete than either compound alone
However, some temporary overlap of GLP-1 effects in the first week is expected, which may cause mild gastrointestinal symptoms
Zhao Y, Zhou Y, Wang D, Huang Z, Xiao X, Zheng Q, et al
Additional considerations include: Dietary quality changes during weight loss programmes Increased urinary magnesium excretion in poorly controlled diabetes (though GLP-1 therapy typically improves glycaemic control) Concurrent medications that may affect magnesium status, such as proton pump inhibitors or diuretics It is important to note that routine magnesium monitoring is not currently recommended in NICE guidance (NG28) for patients on GLP-1 therapy